Asia-Pacific Animal Vaccine Market to Reach $5,289.8 million in 2035, Growing at 8.0% CAGR

Published: Mar 2026

Asia-Pacific Animal vaccine market valued at $2,462.6 million in 2025 and is projected to reach $5,289.8 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The market encompasses preventive biological products developed for livestock and companion animals to control infectious diseases and improve productivity across food-producing and pet animal segments. The market is experiencing steady expansion driven by increasing livestock population, rising demand for animal protein, government-led disease control programs, and growing awareness regarding zoonotic disease prevention. Rapid urbanization and rising disposable income are also contributing to growth in companion animal vaccination. Moreover, technological advancements in vaccine delivery systems, combination vaccines, and improved cold chain infrastructure are strengthening regional market penetration.

Browse the full report description of “Asia-Pacific Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/asia-pacific-animal-vaccine-market

According to the Food and Agriculture Organization, Asia accounts for more than 50% of the global livestock population, creating a substantial addressable market for animal vaccines. Data from the World Organisation for Animal Health indicate increasing reporting and surveillance of transboundary animal diseases across Asia-Pacific, reinforcing the need for large-scale immunization programs. In addition, regional veterinary infrastructure expansion supported by national agriculture ministries and international development agencies is improving vaccine accessibility across rural production systems.

Key Statistics: Asia-Pacific Animal Vaccines at a Glance

  • Asia-Pacific represents over 55% of global poultry production and nearly 40% of global pork output, supporting sustained demand for poultry and porcine vaccines.
  • The region produces more than 60% of global aquaculture output, positioning aquaculture vaccines as one of the fastest-growing segments.

Key Innovators Driving Asia-Pacific Animal Vaccine Transformation

The key players in the Asia-Pacific animal vaccine market include Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc, among others.

  • In July 2025, Zoetis expanded its livestock vaccine portfolio in the Asia-Pacific region with the introduction of updated swine and poultry vaccines intended for use in high-density farming systems. The initiative includes efforts to strengthen distribution networks across China, India, and Southeast Asian countries.
  • In May 2025, Boehringer Ingelheim Animal Health announced the expansion of its recombinant and vectored vaccine manufacturing capabilities in Asia-Pacific. The development is intended to address increasing regional demand for advanced animal vaccines and to support supply chain capacity for disease prevention programs.

Market Coverage

  • The market number available for – 2025-2035
  • Base year- 2025
  • Forecast period- 2026-2035
  • Segment Covered-
    • By Type
    • By Technology
  • Competitive Landscape - Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc, among others.

Key questions addressed by the report.

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Asia-Pacific Animal Vaccine Market Report Segment

By Type

  • Porcine Vaccines
  • Poultry Vaccines
  • Livestock Vaccines
  • Aquaculture Vaccines
  • Companion Animal Vaccines
  • Other

By Technology

  • Live Attenuated Vaccine
  • Killed/Inactive Vaccine
  • Recombinant Vaccine
  • Vectored Vaccine
  • Subunit Vaccine
  • DNA Vaccine
  • Chimeric Vaccine
  • Others

Asia-Pacific Animal Vaccine Market Report Segment by Region

  • China
  • India
  • Japan
  • South Korea
  • Australia and New Zealand
  • ASEAN Economies
  • Rest of Asia-Pacific

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-animal-vaccine-market